person

Louise E.

Country
Sweden
Department
Anestesikliniken

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Cardiovascular and Renal Therapeutics

Focus on anticoagulation strategies for patients with atrial fibrillation and advanced chronic kidney disease stage 5, as well as interventions for heart failure with preserved ejection fraction.

  • Anticoagulation with apixaban in atrial fibrillation and CKD stage 5
  • Mineralocorticoid receptor antagonist therapy in HFpEF

Clinical investigations aim to lower stroke incidence and cardiovascular hospitalization.

Dermatology and Atopic Conditions

Investigations target chronic inflammatory skin disease, specifically atopic dermatitis, and strategies to prevent eczema relapse.

  • Topical moisturizers for atopic dermatitis
  • Eczema relapse reduction with maintenance creams

Outcomes emphasize skin barrier restoration and quality of life.

Diabetes, Metabolism and Wound Healing

Research explores early type 2 diabetes management and healing of diabetic foot ulcer using systemic and topical therapies.

  • SGLT2 inhibitor versus metformin in early type 2 diabetes
  • Local antimicrobial agents for diabetic foot ulcer closure

Efforts aim to improve glycemic control and reduce ulcer‑related complications.

Urology, Oncology and Renal Surgery

Focus includes peri‑operative analgesia for robot‑assisted upper urinary tract procedures and therapeutic approaches to renal malignancy, nephrolithiasis, and renal reflux.

  • Spinal analgesia in robotic upper urinary tract surgery
  • Targeted treatment for renal malignancy
  • Management strategies for nephrolithiasis

Studies seek to enhance recovery and disease‑specific outcomes.

Infectious Disease and Immunology

Investigations address viral prevention through organized HPV vaccination and screening, and immune‑modulating therapy for schizophrenia spectrum disorder.

  • Population‑level HPV vaccination and screening program
  • Rituximab therapy in schizophrenia spectrum disorder

Goals include rapid viral elimination and modulation of neuro‑immune pathways.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.